Cardior Pharmaceuticals in Germany has been developing a new compound it says can “halt and partially reverse cellular pathology” in heart failure patients. 

Going by compensation rates and trajectories, these might be the worst of times to be a physician in the United Kingdom.

Nearly 81% of authors failed to report any ties to the industry, experts detailed Saturday in the Journal of the American College of Radiology. 

“With further tuning and validation, this pipeline may potentially add value in cancer screening, staging, diagnosis and prognosis," experts wrote in Cell Reports Medicine.  
 

Technologist Robert Harrison and his attorneys filed the complaint in 2021, charging that shareholders grossly overpaid in the deal, among other contentions

Healthcare CFOs spend more time dealing with cost management and, by extension, operational issues than any other single set of items on their to-do lists.

While the American College of Cardiology's annual meeting has historically had a more clinical focus, presentations at this year's conference in Atlanta will spend much more time looking at the business side of things. 

The news represents a meaningful policy shift for CMS. In the past, Medicare prescription drug plans have not covered medications designed to help patients lose weight.